BVS vs MTCH · rev $573.3M vs P/E 13, rev $3.48B
Bioventus Inc (BVS) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
BVS currently screens at market cap $495.1M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the BVS and MTCH stock pages for the full models.
Not investment advice.